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Abstract
The capacity of existing blood vessels to give rise to new blood vessels via endothelial cell sprouting is called angiogenesis and is a
well-studied biologic process. In contrast, little is known about the mechanisms for endothelial cell replacement or regeneration
within established blood vessels. Since clear definitions exist for identifying cells with stem and progenitor cell properties in many
tissues and organs of the body, several groups have begun to accumulate evidence that endothelial stem and progenitor cells exist
within the endothelial intima of existing blood vessels. This paper will review stem and progenitor cell definitions and highlight
several recent papers purporting to have identified resident vascular endothelial stem and progenitor cells.
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Somatic stem and progenitor cells provide a source of tissue-
speciﬁc cellular elements that permit appropriate tissue and
organ functions through replacement of injured, diseased,
and senescent cells in many organ systems throughout the
lifespan.1 Hematopoietic,2,3 intestinal,4,5 skin,6,7 and skeletal
muscle stem cells8,9 have been identiﬁed and rigorously stu-
died; however, little is known of the cellular and molecular
mechanisms that give rise to the homeostatic repair and
replacement of vascular endothelial cells. In 1997, Asahara
et al.10 reported on the identiﬁcation of circulating progeni-
tor cells for the endothelial lineage. These putative endothe-
lial progenitor cells (EPC) were bone marrow-derived cells
that displayed an upregulation of ‘‘endothelial’’ cell surface
markers and downregulation of ‘‘hematopoietic’’ markers
during in vitro culture, suggesting that some hematopoietic
stem cells (HSC) displayed the ability to transdiﬀerentiate
into EPC to regenerate endothelial cells in vitro.11,12 These
putative EPCs also displayed colony-forming activity and
were capable of migrating to sites of ischemic injury
in vivo in animal models of human disease. Since these puta-
tive EPCs were isolated from human blood but participated
in neovascularization in the tissues of injured animals,
the authors proposed that the cells were engaged in postna-
tal vasculogenesis as a means to repair the damaged blood
vessels. Numerous publications followed where various cell
surface markers were identiﬁed as enriching for the putative
HSCs that could transdiﬀerentiate into EPC subsets to
enhance vascular repair13,14 (reviewed in Kovacic et al.15)
or could serve as a biomarker for the presence or severity
of cardiovascular disease in humans (reviewed in the
literature16–19).
Subsequent studies have clariﬁed that those putative
EPCs did not possess the capacity to undergo a lineage
fate switch (transdiﬀerentiate) from a hematopoietic precur-
sor to a mature endothelial cell. Instead, a series of papers
demonstrated that the putative EPCs were in fact events in
which labeled donor bone marrow cells either displayed no
evidence of plasticity upon rigorous scrutiny,20–22 displayed
the host phenotype in tissues following transplantation via
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spontaneous cell fusion,23,24 were an artifact of host tissue
autoﬂuorescence,25 or that were erroneously attributed to
becoming integrated in the endothelial intima at sites of
injury, when detailed confocal microscopic analysis deter-
mined that donor bone marrow cells were localized in
peri-endothelial sites and not integrated as endothelial
cells.26 Subsequently, the putative bone marrow-derived
EPCs were shown to be comprised of numerous stages of
hematopoietic stem and progenitor cells (HSPC) that can
serve paracrine proangiogenic functions to promote vascu-
lar repair and replacement through endogenous endothelial
cell mechanisms.20,22,26–35 Indeed, these proangiogenic cells
could upregulate some ‘‘endothelial cell’’ markers in vitro
and thus give the impression they were becoming endothelial
cells; however, functional analysis,36 comparative gene
expression proﬁling,37,38 and analysis of the methylation
status of promoters for key known endothelial regulatory
genes39 conﬁrmed that the proangiogenic cells remained
more closely aligned to HSPC than mature endothelial
cells. Thus, a recent position paper has called for the
substitution of the term myeloid angiogenic cells (MAC)
for the term EPC when considering the reparative role
played by bone marrow hematopoietic-derived cells in the
neovascularization process.31
Some reports have proposed evidence that vascular endo-
thelial cells may also arise from resident vascular progenitor
cells. During murine embryogenesis, mesoangioblasts have
been identiﬁed that emerge from the dorsal aorta and give
rise to endothelial, skeletal muscle, bone, cartilage, and
dermal cells.40 The mesoangioblasts display many properties
similar to pericytes that are important for controlling the
proliferation and diﬀerentiation of capillary endothelial
cells. Whether these pericytes and mesenchymal stem cells
(MSC) within the media and adventitia are resident progeni-
tor cells for all the vascular lineage components has been
reviewed on several occasions.41,42 Greiner et al.43 identiﬁed
stem cell antigen-1 (Sca-1) expressing precursors upon
enzymatic digestion of small murine vessels that displayed
potential to form endothelial cells in vitro and the endothe-
lial cells displayed vasculogenic functions. However, the
location of these cells within the vasculature was not
reported. Zengin et al.44 isolated progenitor cells residing
between the vascular media and adventitial layers of
murine arteries and veins that possessed endothelial cell
phenotypic features and capillary tube forming potential
in vitro. Similar localization of resident angiogenic mesen-
chymal progenitor cells were identiﬁed in human thoracic
aortic samples from humans .45 While interesting, the exact
roles played by these resident multi-potent progenitor cells
in normal endothelial repair and replacement or following
injury has not been pursued or translated into human
studies, perhaps due to the requirement for recovery from
the host vasculature.
Thus, while some data suggest resident vascular progeni-
tor cells may give rise to endothelial cells (among other
lineages), what general evidence has been published that
would suggest the endothelial intima may give rise directly
to reparative or regenerative activity? Obviously, thousands
of papers have been published on the topic of angiogenesis
over the past three decades and it has become very clear that
the systemic circulation can adapt to requirements for more
vasculature or less vasculature to meet homeostatic balance
or in response to tumor invasion via this mechanism.46–48
More than four decades ago, several reports highlighted the
presence of proliferating endothelial cells during rodent
development and that in response to vascular injury, clusters
of replicating endothelial cells could be identiﬁed in areas of
‘‘high turnovers’’49,50 (reviewed in detail in Yoder51). In the
developing mouse embryo, outgrowth of mesoderm-derived
precursors displaying endothelial markers displayed a high
capacity for prolonged proliferation and ability to incorp-
orate into developing chick embryonic vasculature, but such
cells were not prospectively identiﬁed within the embryo,
studied at a clonal level, or examined for chromosomal
abnormalities.52 It has also long been known that among
all adult murine tissues, the lung vasculature is one of the
most readily amenable to use for isolation and cultivation of
endothelial cells that possess proliferative potential.53–55
Several publications have highlighted the capacity for the
endogenous endothelial cells within the lung vasculature to
give rise to replacement endothelial cell progeny that form
new blood vessels upon transplantation56,57 or return vas-
cular function to normal following an acute challenge with
lipopolysaccharide (LPS).58 Others have shown that
removal of the left lung lobe in a rodent results in com-
pensatory overgrowth of the right lung to rescue lung func-
tion, but this lung epithelial expansion is dependent upon
endogenous lung vascular endothelial proliferation and
vascular expansion.59–61 Likewise, active angiogenesis
within the murine skeletal system is required to support
osteogenesis.62 Recently, a novel population of proliferative
capillaries within the bone metaphysis (1.77% of total
endothelium) was identiﬁed that function as a precursor
population to mediate normal growth of the bone vascula-
ture, to respond to various stressors or metabolic
perturbations to rescue damaged skeletal microvasculature,
and were shown to be diminished in concentration with
aging concomitant with loss of osteoprogenitor cells.
These are just a few examples to illustrate the point that
accumulating evidence highlights the resident vascular
endothelium as a source of regenerative endothelium during
development and in response to injury.
The largely unanswered question is whether suﬃcient
evidence exists that well deﬁned endothelial stem and pro-
genitor cells have been identiﬁed in murine tissues and
organs. What criteria have been used to deﬁne such cells?
Have the various putative stem and progenitor cells been
scrutinized to identify similarities or diﬀerences in their loca-
tion, gene expression, fates, and responses to injury?
This paper will now provide a brief overview of common
deﬁnitions for somatic stem and progenitor cells and then
in the light of these terms, review evidence to support the
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identiﬁcation of resident vascular stem and progenitor cells
in mouse and man.
Assays to identify endothelial stem and
progenitor cells
Somatic stem cells can be simply deﬁned as clonally prolif-
erative, self-renewing cells, which give rise to diﬀerentiated
cell types in a particular tissue or organ.1 A somatic stem cell
may be multi-potent (giving rise to multiple types of diﬀer-
entiated cells) or unipotent (diﬀerentiating into a single lin-
eage of mature cells). In general, somatic stem cells are
located within nurturing niches in the tissue or organ for
which they generate replacement progeny; for example,
intestinal stem cells are present within the intestinal epithe-
lium and skin stem cells reside within the dermis (hemato-
poietic stem cells are an exception as they reside in the bone
marrow but their progeny are distributed throughout the
blood and within tissues).2,63–68 Progenitor cells lack self-
renewal potential, however, they may clonally expand
prior to diﬀerentiation into a single lineage of mature
cells. Like somatic stem cells, the majority of somatic pro-
genitor cells reside within the tissues for which they provide
replacement mature cells.
Multiple assays have been developed to deﬁne stem and
progenitor cells that reside in diﬀerent organs and tissues.1
Stem cells in any tissue must be interrogated for clonal
self-renewal. This property is most stringently proven by
long-term in vivo persistence with retained capacity for con-
tribution to diﬀerentiated progeny. In the murine system,
long-term contribution to a particular lineage is best demon-
strated through the use of fate mapping strategies (with or
without induced perturbations or injuries that require cell
replacement). Transplantation assays into primary and sec-
ondary recipient hosts are powerful tools to examine clonal
self-renewal and long-term contributions to particular cell
lineages, but may represent highly stressful and forced
expansion of low numbers of transplanted donor stem
cells into a system in which endogenous progenitor and
mature cells may have been drastically diminished.69–71
Progenitor cells are often measured with colony forming
assays in vitro (to prove a precursor product relationship).
Stem and progenitor cells may also display distinguishing
cell surface markers that can be used to prospectively isolate
the cells through use of monoclonal antibodies and ﬂow
cytometry or magnetic bead separation. Most recently,
stem and progenitor cells from some tissues have become
deﬁnable by single cell gene expression technologies to
permit identiﬁcation by a unique molecular signature.72–79
Presentation of some selected publications (as examples of
detailed approaches to acquire suﬃcient evidence) identify-
ing putative stem and progenitor cells for the vascular
system follows.
To identify stem and progenitor cells for the endothelial
lineage, we ﬁrst need to decide what criteria should be used
to deﬁne cells belonging to the endothelial lineage.
Obviously, there are numerous phenotypic, morphologic,
physiologic, genomic, proteomic, and functional parameters
that constitute unique and characteristic behaviors of endo-
thelial cells. The point here is that one cannot identify cells
of the endothelial lineage by expression of a few cell surface
markers or of a few RNA transcripts. For example, when
using phenotypic markers to enrich for a stem cell popula-
tion, functional evidence for enrichment of the particular
stem cells must be presented as validation for any of the
putative surface markers being highlighted. The best pheno-
typic markers would be unique and restricted to the particu-
lar stem cell being selected; however, this is often not the
case and use of a panel of markers can be very useful in
discriminating a particular stem cell from progenitor or
mature cells within a tissue or organ. Functional evidence
for the stem cell should be performed to provide evidence
that the putative stem cell directly gives rise to progenitor
and mature cells of that tissue or organ (may be conducted
by fate mapping studies and/or transplantation as noted
above). Transcriptomics and proteomics are increasingly
being used at a single cell level to provide novel panels of
enriched genes that are expressed by subsets of stem or pro-
genitor cells within the same tissue or organ.72 Thus, in most
instances, to fully deﬁne a stem or progenitor cell for the
endothelial lineage, one must utilize a panel of phenotypic,
functional, physiologic, morphologic, and ‘‘omics’’ informa-
tion concurrently. A few selected exemplary papers that
have applied many of these principles to deﬁne endothelial
stem and progenitor cells will be presented.
Progenitor cells for the endothelial lineage
Patel et al.80 recently proposed several features that could be
used to deﬁne resident vascular endothelial progenitor cells
for the murine vasculature. In experimentally induced cuta-
neous wounds, most cells expressing CD34 but not CD45
concomitantly expressed CD144, strongly suggesting their
endothelial nature. Within the CD34 and CD144 express-
ing endothelium, the relative level of expression of platelet
endothelial cell adhesion molecule (CD31) and vascular
endothelial cell growth factor receptor 2 (ﬂk1) permitted
discrimination of the endothelial cells into endovascular
progenitor cells (EVP), transient amplifying cells (TA),
and deﬁnitive diﬀerentiated cells (D). Of interest, the EVP
population did not express c-kit, the mesenchymal marker
CD73, or the pericyte marker CD146, but all three popula-
tions expressed Tie-2, Sca-1, and CD90 (Table 1). The EVP,
TA, and D populations were identiﬁed in multiple organs
and tissues with varying frequencies. Using the natural
kinetics of granulation tissue formation following an experi-
mentally induced cutaneous wound,81,82 the kinetics of
appearance in the tissue, change in cell surface marker
expression, and loss of certain populations with diﬀerenti-
ation and maturation suggested a hierarchy and diﬀerenti-
ation sequence from the EVPs which quickly moved into the
tissue then changed to the TA and ﬁnally the D populations
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(Fig. 1). Only the EVP population was capable of giving rise
to colonies of proliferating endothelium in vitro at a clonal
level. While implantation of TA and D populations in
Matrigel plugs for seven days was associated with markedly
reduced recovery, the EVP implanted plugs formed vessels
within the Matrigel in vivo. Lineage tracing experiments
using the vascular endothelial cadherin reporter (Cdh5-
creERt2/ROSA-YFP) mouse to label the EVP within the
center of the wound demonstrated that these precursors
gave rise to YFP expressing blood vessels co-expressing
FLK1 and CD31. Distinct diﬀerences in gene expression
were identiﬁed in the EVP compared to the D populations.
While the EVP population was enriched for matrix metallo-
proteinases and growth factor signaling, the D population
was enriched in endothelial cell surface molecules, Notch
signaling target genes, and the SoxF family of genes
(Sox7, Sox17, and Sox 18). Of interest, Sox18 expression
was upregulated in the EVP population during the initial
phases of wound healing but EVP rapidly diﬀerentiated
into TA and D cells. Loss of Sox18 function studies demon-
strated a defect in diﬀerentiation of EVP cells to TA and D
cells in healing wounds. Thus, evidence for these diﬀerent
populations displaying diﬀerent functional states was
presented using clonogenic in vitro analysis, fate mapping
studies in vivo, transplantation analysis, diﬀerences in gene
expression, diﬀerences in phenotypic analysis (ﬂow cytome-
try and immunoﬂuorescence), and the requirement of
certain transcription factors for the diﬀerentiation of EVP
to D states.80
Evidence for the identiﬁcation of clonogenic human
endothelial progenitor cells (circulating or resident) has
been published by several groups.83–86 Analysis of the circu-
lating blood of patients following a sex-mismatched bone
marrow transplant indicated that most of the circulating
blood outgrowth endothelial cells (BOEC) were derived
from the host, but the delayed outgrowth cells displayed
the most proliferative cells and were donor derived.87
Umbilical cord blood was reported to be enriched for
clonogenic endothelial colony forming cells (ECFC) that
displayed a hierarchy of proliferative potential and
in vivo vessel formation compared to adult peripheral
blood (Fig. 2).88 The highly proliferative ECFC from cord
blood expressed higher levels of telomerase than the ECFCs
cultured from adult peripheral blood cells. Furthermore,
resident vascular endothelial cells derived from umbilical
veins or human abdominal aorta contained clonogenic
ECFCs with vasculogenic potential.89 Very recently,
human-induced pluripotent stem cell (hiPSC)-derived
ECFCs have been reported with properties that are similar
Fig. 1. Evidence for a hierarchy of resident VESCs and progenitor cells. VESCs reside in the endothelial intima of blood vessels. Several markers
for the VESCs have been proposed.71,72,74 The EVPs give rise to TA cells that produce definitive differentiated (D) cells.60 VESCs display the
greatest proliferative potential while the D cells are non-proliferative.
Table 1. Cell surface marker expression.
Marker
Endovascular
progenitor
Transit
amplifying
Definitive
differentiated
VECAD þþþ þþþ þþþ
Tie2 þþþ þþþ þþþ
Sca1 þþþ þþþ þþþ
CD90.2 þþþ þþþ þþþ
CD34 þþþ þ þþþ
CD31 –/þ þþ þþþ
VEGFR2 – þ þþþ
CD105 – þ þþþ
Alpha-6 – þ þþþ
CD146 – þ þþþ
CD73 – – þþ
CD45 – – –
þ, positive staining; –, negative staining.
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to umbilical cord blood ECFCs but with some distinct dif-
ferences in gene expression.90 At present, it is unclear where
the circulating BOECs and ECFCs are derived from; the
most plausible source is the vascular endothelial intima,
but convincing evidence is lacking to support this assertion.
The lack of distinct cell surface markers to prospectively
identify the circulating BOEC and ECFC has been and con-
tinues to be a signiﬁcant impairment to further enrichment
and development of these cells as a therapy for treating
patients suﬀering from a host of cardiovascular disorders.
Vascular endothelial stem cells
Fang et al.91 reported that stem cells for the endothelial
lineage could be isolated from lung blood vasculature.
Vascular endothelial stem cells (VESC) expressing the
phenotype CD31þCD105þSca-1þCD117þ (devoid of any
mature lineage markers for the hematopoietic system)
could be isolated from collagenase digested lung tissue.
Only the VESCs displayed clonogenic colony-forming activ-
ity in vitro at a frequency of approximately six colony-
forming units per 1000 isolated lung endothelial cells.
When the green ﬂuorescent protein (GFP)-tagged VESCs
were suspended in Matrigel and implanted subcutaneously
in mice, the donor GFP-expressing VESCs gave rise
to donor derived blood vessels. Indeed, when 15 VESC-
expressing GFPs were implanted with B16 tumor tissue,
GFP-labeled blood vessels were identiﬁed in primary,
secondary, tertiary, and quarternary tumor implants. Even
a single VESC displayed the capacity to form donor blood
vessels in vivo in a Matrigel implant. When mice deﬁcient in
CD117 expression were examined for endothelial cell
colony-forming activity, a signiﬁcant tenfold reduction in
colony formation was identiﬁed. In addition, blood vessel
density in CD117-deﬁcient mice inoculated with B16 melan-
oma tissue was less than half the density observed in wild
type-mice with the same tumor implants. Thus, the VESCs
identiﬁed by Fang et al.91 are marked by CD117 expression
(Fig. 1) and loss of CD117 expression causes endothelial cell
proliferation and angiogenesis defects. While some ﬂow
cytometric estimations of the frequency of the CD117-
expressing VESCs in diﬀerent tissues was reported, no
detailed visualization of the precise location of the VESCs
in arteries, veins, and capillaries in diﬀerent tissues was pre-
sented. In addition, no fate mapping studies to identify the
contributions of the putative VESCs within various vascular
beds in homeostatic endothelial turnover was presented.
Stem cells from skin, lung, heart, mammary gland,
muscle, and testis have shown evidence for expression of
ATP-binding cassette (Abc) transporters that eﬄux noxious
substrates and molecules outside the cells to maintain their
viability;92 thus, Hoechst 33342 DNA binding dye rapidly
enters into cells but the presence of the Abc transporters
results in eﬄux of the dye in stem cells causing them to
display diminished ﬂuorescence (SP) and permitting their
identiﬁcation and isolation by ﬂow cytometric analysis and
sorting. Summer et al.93 were one of the ﬁrst groups to dem-
onstrate that adult murine lung tissue displayed a SP
(0.3–0.7% of total cells) that appeared stable up through
one year of age. SP cells derived from enzyme-digestion of
the lung tissue were mostly blood cells (CD45þ) but some
non-blood cells also stained. A polyclonal antibody raised
against an internal peptide sequence for breast cancer resist-
ance protein 1 (Bcrp1; Abcg2) was used to demonstrate that
SP cells were Bcrp1þ. While smooth muscle cells and some
distal epithelial cells expressed Bcrp1, these cells did not
display a SP phenotype, suggesting that in these cells,
there was no correlation between Bcrp1 expression and
Fig. 2. Model of a human ECFC hierarchy.68 High proliferative potential-ECFC (HPP-ECFC) display the highest proliferative potential and self-
renew with replating potential. Low proliferative potential-ECFC (LPP-ECFC) form colonies greater in size than endothelial cell clusters but less
than HPP-ECFC and do not possess self-renewal potential. Mature differentiated endothelial cells do not divide.
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function to confer the SP phenotype. More recently, pheno-
typic lung SP cells identiﬁed as MSCs have been isolated
that express Abcg2 and these MSC display properties of
pericytes that contribute to ﬁbrotic remodeling following
injury.94,95 Lung SP cells isolated from embryos at embry-
onic day (E) 13.5–18.5 or postnatal day (P) 13–55 murine
pups were shown to comprise both blood cell (CD45þ) and
non-blood cell (CD45–) subsets.96,97 The CD45þ lung cells
also co-expressed fetal liver kinase 1 (Flk1) but did not
express vascular endothelial cadherin (CD144). Both
CD45þ and CD45– subsets gave rise to cells displaying
phenotypic and some in vitro functional features of endo-
thelial cells. No clonal analysis of ECFC potential, long-
term contribution to lung endothelial retention, or capacity
for vascular regeneration or repair by these precursor cells
was presented.
Naito et al.98 have also used the Hoechst staining
method and have reported the identiﬁcation of resident vas-
cular endothelial cells within the side-population (SP).
Endothelial SP were identiﬁed as dormant cells in the
steady state, but possessed clonal colony-forming activity,
and produced large numbers of mature endothelial progeny
when cultured in vitro. When transplanted into experimen-
tally induced ischemic lesions, the endothelial SP cells
restored blood ﬂow and reconstituted de novo blood vessels
at the site of injection. Although the surface markers of the
SP cells was similar to primary capillary endothelial cells,
the gene expression pattern of the SP, and main population
(MP) that fail to retain the Hoechst dye, was signiﬁcantly
diﬀerent. The endothelial SP cells failed to express hemato-
poietic markers, including c-Kit (CD117), and could not be
detected in bone marrow (Fig. 1). Bone marrow transplant
studies reconstituted the peripheral blood cell lineages, as
would be expected, but did not contribute to vascular endo-
thelial SP cells. Use of the Hoechst method fails to permit
identiﬁcation of the putative VESCs within the organ and
tissue vasculature during development or after injury and
will rely upon further studies to identify novel cell surface
markers. Of interest, several unique cell surface markers
were identiﬁed in the SP cells that may permit prospective
isolation of these putative VESCs.
More recently, Yu et al.99 identiﬁed protein C receptor
(Procr)-expressing endothelial cells as VESCs in the mam-
mary fat pad, skin, and retina. Procr-expressing cells were
identiﬁed in the tip and stalk cells of the pubertal stage of
the mammary fat pad when robust angiogenesis accompa-
nies rapid epithelial growth. In the adult mammary gland,
Procr-expressing cells were predominantly found in the stalk
cells in areas of angiogenesis. When single-cell suspensions
of the mammary gland tissue were prepared and cells
exposed to panels of monoclonal antibodies (all blood
cells identiﬁed and excluded using CD3e, Ly6G/Ly6C,
CD11b, Gr1, CD45R/B220, and Ter119) that included
CD105 and CD31, approximately 4% of the vascular endo-
thelium expressed Procr. Of interest, while> 85% of the
Procr-expressing cells expressed Sca-1, only 2% of the
endothelium expressed c-Kit and expression was in the
Procr-negative fraction of cells. When Procr-expressing
cells isolated from Actin-GFP reporter mice were suspended
in Matrigel and implanted subcutaneously into host ani-
mals, signiﬁcantly more vasculature was formed from cells
expressing Procr than from cells not expressing Procr (this
fraction contained the c-Kit expressing cells). The Procr-
expressing VESCs formed capillary and larger vessels
when injected into the empty fat pad of pubertal host ani-
mals. Procr-expressing VESC displayed clonal proliferative
potential in vitro that was lacking in cells not expressing
Procr and the Procr-expressing VESCs produced endothelial
progeny through ten passages in vitro (Fig. 3). Lineage tra-
cing studies were conducted in pubertal animals and the
Procr-expressing endothelial cells contributed to endothelial
cell expansion for up to ten months in vessels within the
mammary gland. Surprisingly, the VESCs were determined
to be bipotent, with contributions not only to the endothe-
lium but also to pericytes throughout vessels in multiple
tissues. The authors suggested that the VESCs identiﬁed
underwent endothelial to mesenchymal transition to
become the pericyte cells in the vascular beds examined.99
Conclusions
There is a growing body of work to support the concept that
endothelial stem and progenitor cells exist within the endo-
thelial intima of resident tissue vasculature. At present, lim-
ited comparisons among the diﬀerent approaches used by
the authors has been accomplished, but some limitations of
the present work can be identiﬁed. While the work of Patel
et al.80 has shown that endothelial progenitors can be iden-
tiﬁed by applying stringent criteria, the speciﬁc sites of EVP,
TA, and D cell localization in organs and tissues at homeo-
stasis (artery, vein, or capillary bed), the contributions of
EVP to TA and D cells during homeostasis, diﬀerences in
the EVP among diﬀerent organs across the lifespan of the
mouse, and determination of whether the EVP represents an
endothelial stem cell remain to be addressed. Human endo-
thelial progenitor cells (ECFCs) have been identiﬁed;87,88,90
Fig. 3. Procr-expressing endothelial cells display the greatest prolif-
erative potential producing progeny through ten passages while the
Procr-negative fraction fails to proliferate beyond four passages
in vitro74.
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however, no unique identifying markers have permitted pro-
spective isolation of ECFCs from circulating blood or blood
vascular endothelium to permit identiﬁcation of the site of
origin of ECFC in humans and determination of whether
these cells display stem cell activity for the endothelial lin-
eage. Several papers have published evidence for the pres-
ence of resident VESCs in mice; however, the relationship
between the unipotent VESC identiﬁed by Fang et al.91 and
Naito et al.,98 and the bipotent VESC identiﬁed by Yu
et al.99 remains unclear. It is clear that the expression of c-
Kit as a marker for VESC diﬀers in these three papers as it is
a critical marker in the work of Fang et al.,91 but is not
expressed on the SP VESC of Naito et al.98 or the Procr-
expressing VESC of Yu et al.99 Identiﬁcation of unique and
perhaps more distinguishing characteristics of the VESCs
that discriminate these stem cells from progenitor and
mature endothelial elements awaits additional study.
Finally, no cell surface antigen has yet been reported that
can be used to prospectively identify VESCs in mice and
man. This is an exciting and emerging theme that will
impact our understanding of how the vascular endothelium
is organized and replenished throughout the lifespan and
may oﬀer new insights into mechanisms of acquired endo-
thelial dysfunction and development of cardiovascular
disease.
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